Class of diseases that involve the heart or blood vessels.
Chemical process used in the semiconductor industry to produce thin films.
1
This risk is the result of traditional and nontraditional CVD risk factors.
2
Predicted and observed CVD-free survival showed good agreement in all validation sets.
3
Heightened risk of CVD is often attributable to treatment with anthracycline chemotherapy.
4
Participants: Participants with self-reported history of established diagnosis of CVD were excluded.
5
Age-associated changes of such cells may enhance the risk of developing CVD.
6
Conclusion: The data suggest differences in CVD symptoms and clusters by sex.
7
The relationship of dietary caloric intake and CVD risk is less certain.
8
Approximately half of the elderly adults had moderate or high CVD risk.
9
Predictors of rapid kidney decline included prevalent and subclinical measures of CVD.
10
No associations between MAZ-Ab OD and conventional CVD risk factors were identified.
11
Identification of novel therapeutic targets and biomarkers for CVDs is urgently needed.
12
The CVD risk factors were collected at baseline and at 6-month follow-up.
13
To date, no lifetime risk estimates of total CVD have been reported.
14
Nanocomposite films were deposited from the colloid concurrently with conventional CVD precursors.
15
Total CVD included CAD or history of physician-diagnosed stroke or heart failure.
16
CVD risk factors are markedly elevated in HIV-infected patients with fat redistribution.
russo
português
espanhol
